Recent Articles
Can VEGFR Antibodies Become a Ne...
Th1/Th2 Subset Differentiation: ...
Paired Antibodies for Progestero...
PIK3CG (p110γ): Uncovering Potential Targets for Mechanistic Studies of Sepsi...
This inflammation‑cardiology review interprets multi‑omics identification of PIK3CG (p110γ) as hub gene in sepsis‑triggered myocardial injury, dual inflammatory‑cardioprotective functions of PI3Kγ, melatonin‑PIK3CG molecular‑docking findings and pre‑clinical animal‑model observations. It provides...
PIK3CG (p110γ): Uncovering Potential Targets for Mechanistic Studies of Sepsi...
This inflammation‑cardiology review interprets multi‑omics identification of PIK3CG (p110γ) as hub gene in sepsis‑triggered myocardial injury, dual inflammatory‑cardioprotective functions of PI3Kγ, melatonin‑PIK3CG molecular‑docking findings and pre‑clinical animal‑model observations. It provides...
Read More
Leveraging GFP‑Fusion Tags and Anti‑GFP Nanobody Beads for Diverse Target‑Pro...
This molecular‑cell‑biology review covers intrinsic structural features of GFP/EGFP fluorescent tags, anti‑GFP nanobody agarose‑magnetic bead working principles, Co‑IP, GFP‑ChIP, interactome‑proteomics workflows, experimental advantages of VHH‑based affinity resin. It presents Anti‑GFP...
Leveraging GFP‑Fusion Tags and Anti‑GFP Nanobody Beads for Diverse Target‑Pro...
This molecular‑cell‑biology review covers intrinsic structural features of GFP/EGFP fluorescent tags, anti‑GFP nanobody agarose‑magnetic bead working principles, Co‑IP, GFP‑ChIP, interactome‑proteomics workflows, experimental advantages of VHH‑based affinity resin. It presents Anti‑GFP...
Read More
Frontiers in Innovative Pharmaceutical Modalities
 Industry Overview The innovative drug landscape has transitioned from traditional small molecules and monoclonal antibodies into an explosive paradigm of New Modalities: Antibody‑Drug Conjugates (ADCs), Bispecific/Multispecific Antibodies, Targeted Protein...
Frontiers in Innovative Pharmaceutical Modalities
 Industry Overview The innovative drug landscape has transitioned from traditional small molecules and monoclonal antibodies into an explosive paradigm of New Modalities: Antibody‑Drug Conjugates (ADCs), Bispecific/Multispecific Antibodies, Targeted Protein...
Read More
Electrostatic Interactions Governing Initial Triggering Events Within T‑Cell ...
This adaptive‑immunology review interprets electrostatic‑charge‑driven TCR‑signal‑initiation mechanisms, CD3ε basic‑rich‑sequence (BRS) membrane‑shielding, Lck unique‑domain substrate‑selectivity, antigen‑strength‑dependent ITAM‑phosphorylation patterns. It provides Phospho‑Src Family (Tyr416) recombinant rabbit mAb (S0B1068) from ANT BIO PTE....
Electrostatic Interactions Governing Initial Triggering Events Within T‑Cell ...
This adaptive‑immunology review interprets electrostatic‑charge‑driven TCR‑signal‑initiation mechanisms, CD3ε basic‑rich‑sequence (BRS) membrane‑shielding, Lck unique‑domain substrate‑selectivity, antigen‑strength‑dependent ITAM‑phosphorylation patterns. It provides Phospho‑Src Family (Tyr416) recombinant rabbit mAb (S0B1068) from ANT BIO PTE....
Read More
RIPK1 Kinase Activity (Ser166): Regulatory Mechanisms and Biological Outputs ...
This cell‑signalling review interprets TNFR1‑triggered complex‑I/complex‑II signalling cascades, multi‑layered RIPK1 post‑translational regulation (phosphorylation‑ubiquitination), Ser166 autophosphorylation as RIPK1‑kinase activation marker, apoptosis‑necroptosis cell‑fate decisions and RIPK1‑inhibitor pre‑clinical research. It presents Phospho‑RIP (Ser166)...
RIPK1 Kinase Activity (Ser166): Regulatory Mechanisms and Biological Outputs ...
This cell‑signalling review interprets TNFR1‑triggered complex‑I/complex‑II signalling cascades, multi‑layered RIPK1 post‑translational regulation (phosphorylation‑ubiquitination), Ser166 autophosphorylation as RIPK1‑kinase activation marker, apoptosis‑necroptosis cell‑fate decisions and RIPK1‑inhibitor pre‑clinical research. It presents Phospho‑RIP (Ser166)...
Read More
Selective Degradation of Phosphorylated p38 MAPK (Tyr182): Novel Mechanistic ...
This neurodegeneration‑biology review interprets pathological roles of dually‑phosphorylated p38 MAPK (Thr180/Tyr182) in Alzheimer‑disease‑related neuroinflammation, limitations of conventional ATP‑competitive kinase inhibitors, conformation‑selective PROTAC PRZ‑18002 mechanism and 5xFAD mouse in‑vivo experimental outcomes....
Selective Degradation of Phosphorylated p38 MAPK (Tyr182): Novel Mechanistic ...
This neurodegeneration‑biology review interprets pathological roles of dually‑phosphorylated p38 MAPK (Thr180/Tyr182) in Alzheimer‑disease‑related neuroinflammation, limitations of conventional ATP‑competitive kinase inhibitors, conformation‑selective PROTAC PRZ‑18002 mechanism and 5xFAD mouse in‑vivo experimental outcomes....
Read More